Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Outset Medical Inc (NASDAQ: OM) closed at $0.55 in the last session, down -0.09% from day before closing price of $0.55. In other words, the price has decreased by -$0.09 from its previous closing price. On the day, 0.51 million shares were traded. OM stock price reached its highest trading level at $0.562 during the session, while it also had its lowest trading level at $0.54.
Ratios:
We take a closer look at OM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.38 and its Current Ratio is at 5.69. In the meantime, Its Debt-to-Equity ratio is 7.53 whereas as Long-Term Debt/Eq ratio is at 7.46.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on August 08, 2024, Downgraded its rating to Sector Perform and sets its target price to $3 from $6 previously.
On June 21, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $5 to $6.
On April 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 08, 2024, with a $6 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when Trigg Leslie sold 14,611 shares for $0.90 per share. The transaction valued at 13,150 led to the insider holds 880,969 shares of the business.
Nash Marc sold 4,204 shares of OM for $3,784 on Feb 18 ’25. The SVP Operations and R&D now owns 200,764 shares after completing the transaction at $0.90 per share. On Feb 18 ’25, another insider, Brottem John L., who serves as the General Counsel of the company, sold 6,145 shares for $0.90 each. As a result, the insider received 5,530 and left with 175,043 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 146818176 and an Enterprise Value of 72451032. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 1.09. Its current Enterprise Value per Revenue stands at 0.637 whereas that against EBITDA is -0.71.
Stock Price History:
The Beta on a monthly basis for OM is 2.04, which has changed by -0.7235 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, OM has reached a high of $5.22, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is -32.70%, while the 200-Day Moving Average is calculated to be -64.62%.
Shares Statistics:
According to the various share statistics, OM traded on average about 1.10M shares per day over the past 3-months and 725950 shares per day over the past 10 days. A total of 52.94M shares are outstanding, with a floating share count of 51.48M. Insiders hold about 4.48% of the company’s shares, while institutions hold 95.22% stake in the company. Shares short for OM as of 1740700800 were 11230815 with a Short Ratio of 10.18, compared to 1738281600 on 9082314. Therefore, it implies a Short% of Shares Outstanding of 11230815 and a Short% of Float of 21.110001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
